Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Ex Parte Reexam and Litigation Proceedings

Isn't this reexam effective december 2010, weren't the patents approved and then expartes presented were rejected until currwnt re-ex was completed and so this re-ex is dated around mid NOv2009

Share
New Message
Please login to post a reply